These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2404464)

  • 1. Pemphigoid and cancer.
    Lindelöf B; Islam N; Eklund G; Arfors L
    Arch Dermatol; 1990 Jan; 126(1):66-8. PubMed ID: 2404464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan.
    Ogawa H; Sakuma M; Morioka S; Kitamura K; Sasai Y; Imamura S; Inaba Y
    J Dermatol Sci; 1995 Mar; 9(2):136-41. PubMed ID: 7772576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of bullous pemphigoid in Sweden 2005-2012: a nationwide population-based cohort study of 3761 patients.
    Thorslund K; Seifert O; Nilzén K; Grönhagen C
    Arch Dermatol Res; 2017 Nov; 309(9):721-727. PubMed ID: 28875235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid and malignancy.
    Ortíz LJ; Vázquez M; Sánchez JL
    Bol Asoc Med P R; 1990 Oct; 82(10):458-9. PubMed ID: 2080959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid: the frequency of mucosal involvement and concurrent malignancy related to indirect immunofluorescence findings.
    Hodge L; Marsden RA; Black MM; Bhogal B; Corbett MF
    Br J Dermatol; 1981 Jul; 105(1):65-9. PubMed ID: 7020742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of internal malignancies in autoimmune blistering diseases: pemphigus and bullous pemphigoid in Japan.
    Morioka S; Sakuma M; Ogawa H
    Dermatology; 1994; 189 Suppl 1():82-4. PubMed ID: 8049570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of pemphigoid diseases in Northern Germany in 2016 - first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases.
    van Beek N; Weidinger A; Schneider SW; Kleinheinz A; Gläser R; Holtsche MM; von Georg A; Hammers CM; Hübner F; Lima AL; Gola D; Sadik CD; Zillikens D; Katalinic A; Schmidt E; König IR
    J Eur Acad Dermatol Venereol; 2021 May; 35(5):1197-1202. PubMed ID: 33428263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancies in bullous pemphigoid: A controversial association.
    Balestri R; Magnano M; La Placa M; Patrizi A; Angileri L; Tengattini V; Bardazzi F
    J Dermatol; 2016 Feb; 43(2):125-33. PubMed ID: 26435381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic urticaria and cancer: an epidemiological study of 1155 patients.
    Lindelöf B; Sigurgeirsson B; Wahlgren CF; Eklund G
    Br J Dermatol; 1990 Oct; 123(4):453-6. PubMed ID: 2095176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid and malignancy: relationship to indirect immunofluorescent findings.
    Venencie PY; Rogers RS; Schroeter AL
    Acta Derm Venereol; 1984; 64(4):316-9. PubMed ID: 6209889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous pemphigoid: clinico-epidemiological study of patients seen at a Singapore skin hospital.
    Tham SN; Thirumoorthy T; Rajan VS
    Australas J Dermatol; 1984 Aug; 25(2):68-72. PubMed ID: 6397188
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid.
    Baum S; Steinberg S; Tzanani I; Barzilai A; Lyakhovitsky A
    Acta Derm Venereol; 2023 Mar; 103():adv00888. PubMed ID: 36916952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of an association between bullous pemphigoid and psoriasis.
    Grattan CE
    Br J Dermatol; 1985 Sep; 113(3):281-3. PubMed ID: 3904804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid and associated malignant neoplasms.
    Stone SP; Schroeter AL
    Arch Dermatol; 1975 Aug; 111(8):991-4. PubMed ID: 786174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between bullous pemphigoid and malignancy: A meta-analysis.
    Lucariello RJ; Villablanca SE; Mascaró JM; Reichel M
    Australas J Dermatol; 2018 Nov; 59(4):253-260. PubMed ID: 29313891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psoriasis and bullous pemphigoid].
    Bork K
    Hautarzt; 1987 Jun; 38(6):348-51. PubMed ID: 3308771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.
    Bertram F; Bröcker EB; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2009 May; 7(5):434-40. PubMed ID: 19170813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous Pemphigoid: Validation of the National Patient Register in Two Counties in Sweden, 2001 to 2012.
    Grönhagen C; Nilzén K; Seifert O; Thorslund K
    Acta Derm Venereol; 2017 Jan; 97(1):32-35. PubMed ID: 27171523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid.
    Kelly SE; Wojnarowska F
    Br J Dermatol; 1988 Jan; 118(1):31-40. PubMed ID: 3277659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.